| Size | 10 mL vial |
| Concentration | 50 mg/10 mL (5 mg/mL) |
| Unit of Sale | 10 vials per carton |
| Type | Rx |
| Storage | Store at 20° to 25°C (68° to 77°F) |
| Active | 50 mg ephedrine sulfate |
| Inactive | Sodium chloride |
| Preservative-free | Yes |
| Latex-free | Yes – Vial closure is not made with natural rubber latex |
| Allergen-free | Yes |
| Wholesaler | Item Number |
| Cardinal | 5644521 |
| McKesson | 1538644 |
| Morris & Dickson | 903617 |
| Amerisource Bergen | 10235817 |
| Size | 10 mL syringe |
| Concentration | 50 mg/10 mL (5 mg/mL) |
| Unit of Sale | 10 syringes per carton |
| Type | Rx |
| Storage | Store at 20° to 25°C (68° to 77°F) |
| Active | 50 mg ephedrine sulfate |
| Inactive | Sodium chloride |
| Preservative-free | Yes |
| Latex-free | Yes – Closure is not made with natural rubber latex |
| Allergen-free | Yes |
| Wholesaler | Item Number |
| Cardinal | 5831920 |
| McKesson | 2688588 |
| Morris & Dickson | 261073 |
| Amerisource Bergen | 10277819 |
| Size | 5 mL syringe |
| Concentration | 25 mg/5 mL (5 mg/mL) |
| Unit of Sale | 10 syringes per carton |
| Type | Rx |
| Storage | Store at 20° to 25°C (68° to 77°F) |
| Active | 25 mg ephedrine sulfate |
| Inactive | Sodium chloride |
| Preservative-free | Yes |
| Latex-free | Yes – Closure is not made with natural rubber latex |
| Allergen-free | Yes |
| Wholesaler | Item Number |
| Cardinal | 5831912 |
| McKesson | 2688596 |
| Morris & Dickson | 261056 |
| Amerisource Bergen | 10277755 |
Under the Controlled Substances Act (CSA), your state may require additional licensing for dispensing EMERPHED® ready-to-use ephedrine.
For questions, please contact customer service at 888‑806‑4606.
CONTRAINDICATIONS
None
WARNINGS AND PRECAUTIONS
EMERPHED® can cause pressor effects with concomitant use with oxytocic drugs. Can also cause tachyphylaxis with repeated administration of ephedrine.
ADVERSE REACTIONS
Most common adverse reactions during treatment: nausea, vomiting, and tachycardia.
To report SUSPECTED ADVERSE REACTIONS, contact Nexus Pharmaceuticals at (855) 642-2594 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
DRUG INTERACTIONS
Can include: interactions that augment pressor effect; interactions that antagonize the pressor effect; guanethidine; rocuronium; epidural anesthesia; theophylline; cardiac glycosides.
OVERDOSAGE
Overdose of EMERPHED® can cause a rapid rise in blood pressure. In the case of an overdose, careful monitoring of blood pressure is recommended. If blood pressure continues to rise to an unacceptable level, parenteral antihypertensive agents can be administered at the discretion of the clinician.
INDICATIONS AND USAGE
Ephedrine Sulfate injection is an alpha- and beta-adrenergic agonist and a norepinephrine-releasing agent that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia.
For more information, see full Prescribing Information.